Efficacy and safety of infliximab in patients with autoimmune hepatitis.

MLA

Efe, Cumali, et al. “Efficacy and Safety of Infliximab in Patients with Autoimmune Hepatitis.” Hepatology (Baltimore, Md.), Sept. 2024. EBSCOhost, https://doi.org/10.1097/HEP.0000000000001089.

APA

Efe, C., Lytvyak, E., Eşkazan, T., Liberal, R., Androutsakos, T., Turan Gökçe, D., Terziroli Beretta-Piccoli, B., Janik, M., Bernsmeier, C., Arvaniti, P., Milkiewicz, P., Batibay, E., Yüksekyayla, O., Ergenç, I., Arikan, Ç., Stättermayer, A. F., Barutçu, S., Cengiz, M., Gül, Ö., … Higuera-de la Tijera, F. (2024). Efficacy and safety of infliximab in patients with autoimmune hepatitis. Hepatology (Baltimore, Md.). https://doi.org/10.1097/HEP.0000000000001089

Chicago

Efe, Cumali, Ellina Lytvyak, Tuğçe Eşkazan, Rodrigo Liberal, Theodoros Androutsakos, Dilara Turan Gökçe, Benedetta Terziroli Beretta-Piccoli, et al. 2024. “Efficacy and Safety of Infliximab in Patients with Autoimmune Hepatitis.” Hepatology (Baltimore, Md.), September. doi:10.1097/HEP.0000000000001089.